Interview with Andreas Norlin, CSO

2025-04-03

Andreas Norlin, Chief Scientific Officer at Ascelia Pharma shares insights into the company’s latest developments and our plan for the NDA submission


Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all